Socio-Psychological Factors of Compliance of Patients with Schizophrenia

Purpose: analysis of the literature on the influence of socio-psychological factors on the complimentary behavior of patients with schizophrenia. Material: according to the keywords “schizophrenia”, “compliance”, “adherence to treatment”, “awareness of the disease”, “psychological factors”, “social factors”, “psycho-education”, “family therapy”, articles of domestic and foreign authors were selected and studied, devoted to the problem of compliance with schizophrenia patients and published in the last two decades. To compile a literature review, articles in the MedLine/PubMed, eLIBRARY, databases were selected and analyzed, relevant links in the literature lists of the analyzed articles. Discussion: analysis of publications showed that at present, numerous factors have been identified that affect the compliant behavior of schizophrenia patients, among which factors associated with the clinical picture of the disease, cultural and religious characteristics of individuals, medication, the organization of medical care, and many others have been identified. The article most thoroughly discusses the socio-psychological factors of schizophrenia patients’ compliance — the internal picture of the disease, the emotional response of the patient and his relatives to the disease, the therapeutic alliance with specialists of the psychiatric service and a number of other factors. The relationship of the schizophrenia patients’ compliance with their cognitive, emotional and motivational-behavioral spheres of personality was considered. Conclusion: compliance of patients with schizophrenia can improve the combination of drug therapy with psychoeducational work. A psychoeducation program should be available to most of them. Given the influence of relatives on the formation of compliance with schizophrenia patients, it is necessary to include family therapy in treatment and rehabilitation programs of psychiatric institutions.

1. Danilov DS. Komplaens v medicine i metody ego optimizacii (klinicheskie, psixologicheskie i psixoterapevticheskie aspekty). Psixiatriya i psixofarmakoterapiya. 2008;1(10):13–17. (In Russ.).

2. Avedisova AS, Borodin VI. Ot nonkomplaensa k otkazu ot psixofarmakoterapii. Psixiatriya i psixofarmakoterapiya. 2005;7(6):316–318. (In Russ.).

3. Yastrebov VS, Solokhina TA, Shevchenko LS, Lyubov EB, Mitixin VG. Stoimostnoj analiz v psixiatrii: sovershenstvovanie metodologii, metodiki ego provedeniya i utochnenie rezul`tatov. Psychiatry. 2013;3(59):41–47. (In Russ.).

4. Day JC, Bentall RP, Roberts C. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch. Gen. Psychiatry. 2005;62(7):717–724. https://DOI.org/10.1001/archpsyc.62.7.7174

5. Emsley R, Oosthuizen P, Koen L. Comparison of treatment response in second-episode versus first-episode schizophrenia. Journal Clinical Psychopharmacol. 2013;33(1):80–83. https://DOI.org/10.1097/JCP.0b013e31827bfcc1-2013-33-1-80-83

6. Kane John M, Kishimoto T, Correll C. Nesoblyudenie rezhima lecheniya pacientami s psixoticheskimi rasstrojstvami: e`pidemiologiya, predraspolagayushhie faktory` i taktika. World Psychiatry. 2013;12(10):216–226. (In Russ.). https://DOI.org/10.1002/wps.20060-2013-12-10-216-226

7. Berezancev AYu, Mitrofanava OI. Gender, komplaens i kachestvo zhizni bol`ny`x shizofreniej (analiticheskij obzor). Rossijskij psixiatricheskij zhurnal. 2009;(1):24–32. (In Russ.).

8. Grunebaum MF, Weiden P J., Olfson M. Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study. The Journal of Clinical Psychiatry. 2001;62(5):394–395.

9. Donohoe G, Owens N, Donnell CO. Predictors of compliance with neuyroleptic medication among inpatients with schizophrenia: a discriminant function analysis. European Psychiatry. 2001;16(5):293–98. https://DOI.org/10.1016/s0924-9338(01)00581-8.-2001-16-5-293-298

10. Berg JS, Dishler J, Wagner DJ. Medication compliance a health-care problem. Annals Pharmacother. 1993;27(9):1–24.

11. Rotshtejn VG, Bogdan GA, Fomin ME, Suetin SV, Golubeva TP. K probleme komplaentnosti (farmakoe`pidemiologicheskoe issledovanie). Psychiatry. 2005;2(14):55–62. (In Russ.).

12. Grechko TY. Faktory`, vliyayushhie na kompalens v sovremenny`x usloviyax psixiatrii. Nauchnomedicinskij vestnik Central`nogo Chernozem`ya. 2009;(35):72–75. (In Russ.).

13. Solokhina TA. Socialno-psihologicheskie problemi v semyah bolnih shizofreniei i puti ih resheniya. Psihicheskoe zdorove i obrazovanie: sbornik nauchnih statei po materialam II Kongressa “Psihicheskoe zdorove cheloveka XXI veka”. 2018;199–203. (In Russ.).

14. Award AG. Antipsychotic Mediations Compliance and Attitudes Towards Treatment. Current Opion Psychatry. 2004;17(2):75–80. http://dx.DOI.org/10.1097/00001504-200403000-00002-2004-17-2-75-80

15. Neznanov NG, Vid VD. Problema komplaensa v klinicheskoj psixiatrii. Psixiatriya i psixofarmakoterapiya. 2004;6(4):159–162. (In Russ.).

16. Yastrebova VV., Solokhina TA, Mitixin VG, Alieva LM, Mashoshin AI. Priverzhennost` lecheniyu bol`ny`x shizofreniej i razrabotka mer po eyo povy`sheniyu. Psixoterapiya i psixosocial`naya rabota v psixiatrii. Vy`pusk III. Pod red. O.V. Limankina, S.M. Babina. SPb.: Izdatel`stvo «Taro». 2016;334–341. (In Russ.).

17. Kritskaya VP, Meleshko TK, Polyakov YuF. Patologiya psixicheskoj deyatel`nosti pri shizofrenii: motivaciya, obshhenie, poznanie. M. 1991. (In Russ.).

18. Dityatkovskij MA, Aristova TA, Koczyubinskij AP, San`kova AM. Znachenie kognitivny`x stilej v sisteme psixologicheskoj adaptacii bol`ny`x shizotipicheskimi rasstrojstvami. Obozrenie psixiatrii i medicinskoj psixologii imeni V.M. Bextereva. 2006;3(3):26–29. (In Russ.).

19. Solokhina TA, Mitixin VG, Yastrebova VV, Alieva LM, Mashoshin AI. Priverzhennost` rodstvennikov bol`ny`x shizofreniej ix lecheniyu i strategii ee povy`sheniya. Psixoterapiya i psixosocial`naya rabota v psixiatrii. Vy`pusk III. Pod red. O.V. Limankina, S.M. Babina. SPb. Taro. 2016;334–341. (In Russ.).

20. Luriya AR. Vnutrennyaya kartina bolezni i iatrogenny`e zabolevaniya. M.: Medicina. 1977;37–52. (In Russ.).

21. Lutova NB. Komplaens i psixopatologicheskaya simptomatika. Obozrenie psixiatrii i medicinskoj psixologii. 2012;(3):59–64. (In Russ.).

22. Lozhkina LI. Compliance as an actual problem of medical psychology theoretical and methodological aspects. News of Saratov University. 2015;15(3):75–79. https://DOI.org/10.18500/1819-7671-2015-15-3-75-80 (In Russ.).

23. Irzhevskaya VP. Svyaz` narusheniya osoznaniya psixicheskoj bolezni i xarakteristik e`mocional`no-volevoj sfery` u pacientov s shizofreniej. Ucheny`e zapiski imeni PF. Lesgafta. 2009;1(47):47–52. (In Russ.).

24. Amador XF, David AS. Insight and psychosis. N. Y.: Oxford Univer. Press, 1998.

25. Amador XF, Kronengold H. The description and meaning of insight in psychosis. Amador XF., David AS. (eds). Insight and psychosis. N.Y.Oxford University Press, 1998;15–32.

26. Carpenter WT, Strauss JS., Bartko JJ. Flexible system for the diagnosis of schizophrenia: Report from the WHO international pilot study of schizophrenia. Science. 1973;(182):1275–1277.

27. Irzhevskaya VP, Rupchev GE., Txostov A.Sh., Morozova MA. Problema insajta v sovremennoj patopsixologii. Voprosy` psixologii. 2008;(2):145–153. (In Russ.).

28. David AS. The clinical importance of insight. Amador XF., David AS. (eds). Insight and psychosis. N.Y.Oxford University Press, 1998;332–352.

29. McEvoy JP. The relationship between insight in psychosis and compliance with medications. Amador XF., David AS. (eds). Insight and psychosis. N.Y.: Oxford University Press 1998;289–306.

30. Freudenreish O, Cather C. Antipsychotic medication nonadherence: risk factors and remedie. Clinical Synthesis. 2012;(10):124–129.

31. Lutova NB, Petrovskaya IN, Vid VD. Soznanie bolezni i komplajens bol`ny`x psixozami. Obozrenie psixiatrii i medicinskoj psixologii. 2014;(1):10–15. (In Russ.).

32. Zejgarnik BV. Patopsixologiya. M.: Izd. Moskovskogo universiteta. 1986:286. (In Russ.).

33. Kozhuxovskaya II, Zejgarnik BV. Narushenie kritichnosti v strukture deyatel`nosti. Vestnik Moskovskogo Universiteta. Psixologiya. 1978;(1):57–63. (In Russ.).

34. Kozhuxovskaya II. O neobxodimosti differencirovat` ponyatie “kritichnost». Zhurnal nevropatologii i psihiatrii imeni S.S. Korsakova. 1972;(11):12–18. (In Russ.).

35. Arfaoui S. Therapeutic compliance in schizophrenia: the influence of psychotic symptoms and the insight. European Psychiatry. 2013;28;(1):1. https://DOI.org/10.1016/S0924-9338(12)75372-5-2013-28-1-1.

36. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O’Callaghan E. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatric Services. 2001;52(2):161–63. https://DOI.org/10.1176/appi.ps.-2001-52-2-161-163.3

37. Lincoln T. Correlates and long-term consequences of poor insight in patientsd with shizophrenia. A systematic review. Schizophr. Bull. 2007;33.(7):1324–42. https://DOI.org/10.1093/schbul/sbm002

38. Kemp R, Kirov GB. Everitt. Randomised controlled trial of compliance therapy. B. J. Psych. 1998;172(5):413–19. https://DOI.org/10.1192/bjp-1998-172-5-413-419

39. Staring A. Why do patients with schizophrenia who have poor insight still take antipsychotics? Memory deficits as moderators between adherence belief and behavior. Journal Psychiatr. Pract. 2011;17(5):320–329. https://DOI.org/10.1097/01.pra.0000405362.95881.48

40. Tharani A. Compliance to antipsychotic medication: a challenge for client, family and health care providers. J. Pakistan Med. Assoc. Ass. 2013;4:516–518. https://ecommons.aku.edu/pakistan_fhs_son/119

41. Dam J. Insight in schizophrenia: a review. Nord J. Psychiat. 2006;60(2):114–20. https://DOI.org/10.1080/08039480600600185-2006-60-2-114-120

42. Acosta FJ. Evaluation of non compliance in schizophrenia patients using electronic monitoring (MUMS) and its relationship to sociodemographic clinical and psychopathological variable. Shizoprenia Research. 2009;107(2–3):213–217. https://DOI.org/10.1016/j.schres.2009-107-2-3-213-217

43. Amador X. Poor insight in schizophrenia: overview and impact on medication compliancе. Psychresident. 2007;(7):1–6.

44. Moritz S, Peters MJ, Karow A, Deljkovic A, Tonn P, Naber D. Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Mental Illness. 2009;17(1):2. https://DOI.org/10.4081/mi.2009-17-1-2

45. Lazarus RS. Coping theory and research: Past, present, and future. Psychosom Med. 1993;55:234–247.

46. Amador XF, Strauss D H, Yale SA, Flaum MM. Endicott, J. The assessment of insight in psychosis. Am. J. Psychiatry. 1993;(150):873–879. https://DOI.org/10.1176/ajp.-1993-150-6-873-879

47. Kolpakov YaV. Motivacionnoe konsul`tirovanie i priverzhennost` lecheniyu pri razlichny`x zabolevaniyax. Sb. trudov XXIX Itogovoj konferencii molody`x ucheny`x MGMSU. Pod obshh. red. IYu. Lebedenko. M.: MGMSU. 2007;165–166. (In Russ.).

48. Semenova ND. Motivacionny`e faktory` i psixosocial`naya terapiya shizofrenii. Social and Clinical Psychiatry. 2009;19(2):76–83. (In Russ.).

49. Erzin AI. Kognitivny`e, motivacionny`e i cennostnosmy`slovy`e faktory` proaktivnosti pri pervom e`pizode shizofrenii. Medicinskaya psixologiya v Rossii: e`lektron. nauch. zhurn. 2017;93(44):6. (In Russ.).

50. Kolotil`shhikova EA, Mizina EB, Poltorak SV, Chexlaty`j EI. Motivaciya v psixoterapii (obzor literatury`). Obozrenie psixiatrii i medicinskoj psixologii imeni V.M. Bextereva. 2011;(2):13–16. (In Russ.).

51. Yaltonskij VM. Teoreticheskaya model` motivacii k lecheniyu zavisimosti ot psixoaktivny`x veshhestv. Voprosy` narkologii. 2009;(6):8–76. (In Russ.).

52. Danilov DS. Terapevticheskoe sotrudnichestvo (komplaens): soderzhanie ponyatiya, mexanizmy` formirovaniya i metody` optimizacii. Nevrologiya, nejropsixiatriya, psixosomatika. 2014;(2):4–12. (In Russ.). http://dx.DOI.org/10.14412/2074-2711-2014-2-4-12

53. Pugovkina OD, Xolmogorova AB. Terapevticheskij al`yans kak nespecificheskij faktor razlichny`x form psixoterapii i psixofarmakoterapii. Sovremennaya terapiya psixicheskix rasstrojstv 2011;(3):14–21. (In Russ.).

54. Sokolov VP, Belokrylov IV. Problema komplaensa v psihiatrii. Elektronnyj nauchno-obrozovatel’nyj vestnik. Zdorov’e i obrazovanie v XXI veke. 18–20 dekabrya 2017. 2017;19(12):254–255. (In Russ.). http://dx.DOI.org/10.26787/nydha-2226-7417-2017-19-12-254-255

55. Borodin VI, Puchkov II. Otkazy` ot psixofarmakoterapii pri depressivny`x rasstrojstvax i ix prichiny. Rossijskij psixiatricheskij zhurnal. 2005;(2):61–67. (In Russ.).

56. Solokhina TA, Yastrebova VV. Kompleksnaya programma psixosocial`noj reabilitacii v ramkax obshhestvennoj organizacii: metodicheskie osnovy` i ocenka e`ffektivnosti. Psixicheskoe zdorov`e cheloveka i obshhestva. Aktual`ny`e mezhdisciplinarny`e problemy`. Nauchno-prakticheskaya konferenciya 30 oktyabrya 2017 g., Moskva): Sbornik materialov pod red. GP Kostyuka. M. KDU, Universitetskaya kniga. 2018:741–753. (In Russ.).

57. Yastrebova VV. Obshhestvenny`e formy` pomoshhi v psixiatrii: istoriya i sovremennost`. Pod redakciej TA. Solokhinoj, VV Yastrebovoj. M., Gorodecz. 2019;230–252. (In Russ.).

58. Babin SM, Vasil`eva AV, Shlafer AM. Komplaens-terapiya (kratkosrochnaya kognitivno-povedencheskaya metodika) i soblyudenie rezhima lecheniya u bol`ny`x shizofreniej. Psixiatriya i psixofarmakoterapiya. 2012;14(1):9–16. (In Russ.).

59. Hritinin DF, Nekrasov MA. Vliyanie psixicheskoj bolezni na semejnoe okruzhenie pacienta (rezul`taty` sociologicheskogo oprosa). Zhurnal nevrologii i psihiatrii imeni S.S Korsakova. 2013;(9):75–78. (In Russ.).

60. Rivkina NM, Sal`nikova LI. Rabota s sem`yami v sisteme psixosocial`noj terapii bol`ny`x shizofreniej i rasstrojstvami shizofrenicheskogo spektra s pervy`mi psixoticheskimi e`pizodami. Social and Clinical Psychiatry 2009;(3):42–49. (In Russ.).

61. Polotnyanko AN, Tereshhenko IS, Vologzhanina GA. Modeli vzaimodejstviya “vrach–pacient” v ostrom psixiatricheskom stacionare. Pravovy`e i e`ticheskie problemy` psixiatricheskoj pomoshhi. Materialy` nauchno-prakticheskoj konferenci. M. 2009;30(11):143–44. (In Russ.).

62. Bebbington P, Kuipers L. The clinical utility of expressed emotion in schizophrenia. Acta Psychiatr. Scand. Suppl. 1994;(382):46–53.

63. Falloon IRH., Libermann RP, Lillie F.J, Vaughn CE. Family therapy of schizophrenics with high risk of relapse. Family Process. 1981;20(2):211–21.

64. Bocharov VV, Iovlev BV, Korman TA. Klinikopsixologicheskie aspekty` issledovanij rodstvennikov bol`ny`x shizofreniej. Obozrenie psixiatrii i medicinskoj psixologii imeni V.M. Bextereva. 2009;(2):9–12. (In Russ.).

65. Gutkevich EV, Semke AV. Semejny`e mexanizmy` adaptacii pri shizofrenicheskix rasstrojstvax. Sibirskij vestnik psixiatrii i narkologii. 2012;3(72):12–14. (In Russ.).

66. Awad AG, Voruganti LN. The burden of schizophrenia on caregivers: a review Pharmacoeconomics. 2008;26(2):149–162. https://DOI.org/10.2165/00019053-2008-26-149-162

67. Hou SY, Ke CL, Su YC, Lung FW, Huang CJ. Exploring the burden of the primary family caregivers of schizophrenia patients in Taiwan. Psychiatry Clin. Neurosci. 2008;62(5):508–514. https://DOI.org/10.1111/j.14401819-2008-62-5-508

68. Hadrys T, Adamowski T, Kiejna A. Mental discorder in Polish families: is diagnosis a predictor of caregivers burden? Soc. Psychiatry Epidemiol. 2011;46:5:363–372. https://DOI.org/10.1007/s00127-010-0200-8

69. Abramova MV, Enikolopov SN, Kaz`mina OYu. Vliyanie semejny`x otnoshenij na social`nuyu adaptaciyu bol`ny`x shizofreniej. Voprosy` psixologii. M., 2009;(6):81–90. (In Russ.).

70. Lutova MB, Makarevich OV. Vzaimosvyaz` parametrov terapevticheskogo al`yansa i tipa otnosheniya sem`i k lecheniyu u bol`ny`x shizofreniej. Obozrenie psixiatrii i medicinskoj psixologii imeni V.M. Bextereva. 2012;(4):54–57. (In Russ.).

71. Lutova MB, Makarevich OV. Vliyanie sem`i na medikamentozny`j komplajens bol`ny`x shizofreniej. Obozrenie psixiatrii i medicinskoj psixologii imeni V.M. Bextereva. 2010;(2):31–34. (In Russ.).

72. Yastrebov VS, Solokhina TA, Ry`tik EG, Yastrebova VV. Balabanova VV, Shevchenko LS, Dvenadczat` lekcij o psixiatrii i psixicheskom zdorov`e. M.: MBA. 2018;196. (In Russ.).

73. Solokhina TA, Yastrebova VV, Alieva LM. Innovation and reform potential of the public organization “Family and Mental Health”. Psychiatry. 2018;79(3):13–22. (In Russ.). https://DOI.org/10.30629/2618-6667-2018-79-13-22

74. Yastrebova VV, Solokhina TA. Clinical, social and psychological aspects of rehabilitation work in a public organization: assessment of effectiveness. Psychiatry. 018;(3):51–60. (In Russ.). https://DOI.org/10.30629/2618-6667-2018-79-51-60